查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1949821

2026年全球可生物降解医用聚合物市场报告

Biodegradable Medical Polymers Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，可生物降解医用聚合物市场发展迅速，预计将从2025年的27.8亿美元成长到2026年的32.4亿美元，复合年增长率达16.7%。过去几年的成长可归因于可吸收缝合线使用量的增加、可生物降解植入的早期应用、整形外科和心血管外科手术的扩展、聚合物化学的进步以及人们对可吸收材料的接受度不断提高。

预计未来几年，可生物降解医用聚合物市场将快速成长，到2030年市场规模将达到59.5亿美元，复合年增长率（CAGR）为16.4%。预测期内的增长可归因于微创手术需求的不断增长、对永续医用材料日益增长的兴趣、药物-医疗设备混合产品的扩张、再生医学投资的增加以及精密聚合物工程技术的进步。预测期内的主要趋势包括：生物可吸收植入材料的使用日益增多、对可控降解聚合物的需求不断增长、聚合物在药物输送系统中的应用日益广泛、先进生物聚合物加工技术的进步以及对生物相容性和安全性的日益重视。

微创手术需求的不断增长预计将推动可生物降解医用聚合物市场的未来扩张。微创手术是一种采用微小切口或非侵入性方式进行手术和介入的医疗技术，与传统手术方法相比，可减少组织损伤、缩短恢復时间并减轻术后不适。医疗技术的进步促进了精准手术技术的广泛应用，从而推动了此类手术数量的成长。可生物降解医用聚合物透过製造可在体内自然溶解的临时植入、缝线和药物输送装置，为微创手术提供支援。这避免了手术取出，减少了组织损伤，并降低了患者的风险，促进了康復。例如，总部位于美国的专业组织——美国整形外科医师协会在2023年2月报告称，微创美容手术的数量将从2022年的2370万例增加到2023年的2540万例。这种对微创手术日益增长的需求正在推动可生物降解医用聚合物市场的成长。

生物降解医用聚合物市场的主要企业正优先采用先进技术，例如生物聚合物技术，以提升医疗设备和药物输送系统的性能、生物相容性和永续性。生物聚合物技术是将天然来源的聚合物应用于科学领域，以製造用于医疗、包装和工业应用的生物降解、环境永续材料，同时减少对合成塑胶的依赖。例如，总部位于瑞士的上市公司苏尔寿（Sulzer）于2023年11月宣布推出CAPSUL，这是一项用于连续生产生物降解聚酯聚己内酯（PCL）的创新端到端授权技术。这将使该公司能够以经济高效的价格提供高品质的PCL产品。此举旨在推广永续和生物降解材料，提高生产效率，并为医疗和工业应用提供高品质的环保聚合物。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球可生物分解医用聚合物市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 永续性、气候技术和循环经济
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 生物可吸收植入材料的使用日益增多
    • 对可控降解聚合物的需求不断成长
    • 聚合物在药物传递系统中的广泛应用
    • 扩展先进生物聚合物加工技术
    • 日益重视生物相容性和安全性

第五章 终端用户产业市场分析

  • 医疗设备製造商
  • 製药公司
  • 生技公司
  • 研究与开发实验室
  • 契约製造组织

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球可生物降解医用聚合物市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球可生物降解医用聚合物市场规模、对比及成长率分析
  • 全球可生物降解医用聚合物市场表现：规模与成长，2020-2025年
  • 全球可生物降解医用聚合物市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 依产品类型
  • 聚乳酸、聚乙醇酸、聚己内酯、聚羟基烷酯及其他产品
  • 依材料类型
  • 陶瓷基质复合材料（CMC）、氧化物陶瓷、非氧化物陶瓷、先进多孔陶瓷
  • 按产品形式
  • 粉末、磁砖、涂料、纤维、散装
  • 透过使用
  • 药物传输、植入、缝合线及其他应用
  • 按类型细分：聚乳酸
  • 乳酸衍生的聚合物、乳酸共聚物、三维复合聚乳酸
  • 按类型细分：聚乙醇酸
  • 乙醇酸均聚物，与其他单体的共聚物
  • 按类型细分：聚己内酯
  • 锁状聚己内酯、支链聚己内酯、交联聚己内酯
  • 按类型细分：聚羟基烷酯
  • 聚羟基丁酸酯、聚羟基戊酸酯、聚羟基丁酸羟基戊酸酯
  • 按类型细分：其他产品
  • 淀粉基聚合物、纤维素基聚合物、蛋白质基聚合物

第十章 区域与国家分析

  • 全球可生物降解医用聚合物市场：按地区、业绩和预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球可生物降解医用聚合物市场：按国家/地区、性能和预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 生物可降解医用聚合物市场：竞争格局及市场占有率（2024年）
  • 生物可降解医用聚合物市场：公司评估矩阵
  • 生物可降解医用聚合物市场：公司概况
    • Evonik Industries AG
    • Corbion NV
    • dsm-firmenich AG
    • Mitsui Chemicals Inc.
    • Poly Medicure Limited

第37章：其他领先和创新企业

  • KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年生物可降解医用聚合物市场：提供新机会的国家
  • 2030年生物可降解医用聚合物市场：充满新机会的细分市场
  • 2030年生物可降解医用聚合物市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH6MBMPE01_G26Q1

Biodegradable medical polymers are a category of cutting-edge materials designed to break down into non-toxic byproducts in the body or environment once their medical function is fulfilled. They minimize postoperative issues, promote the body's natural recovery, and remove the necessity for surgical removal. With superior biocompatibility and precise degradation control, they play a vital role in progressing contemporary medical therapies.

The primary product types of biodegradable medical polymers include polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxyalkanoates, and others. Polylactic acid is a biodegradable thermoplastic sourced from renewable materials like corn starch and sugarcane, commonly applied in medical and packaging uses. The different material types encompass ceramic matrix composites (CMC), oxide ceramics, non-oxide ceramics, and advanced porous ceramics. The various product forms consist of powder, tiles, coatings, fibres, and bulk. These serve applications such as drug delivery, implants, sutures, and others.

Tariffs are influencing the biodegradable medical polymers market by increasing costs of imported raw materials, specialty monomers, processing equipment, and quality testing instruments used in polymer synthesis and fabrication. Medical device and pharmaceutical manufacturers in North America and Europe are most affected due to dependence on imported high-purity materials, while Asia-Pacific faces pricing pressure on export-oriented polymer production. These tariffs are raising production costs and impacting pricing strategies. However, they are also encouraging regional sourcing of bio-based feedstocks, domestic polymer manufacturing, and innovation in cost-efficient biodegradable material formulations.

The biodegradable medical polymers market research report is one of a series of new reports from The Business Research Company that provides biodegradable medical polymers market statistics, including biodegradable medical polymers industry global market size, regional shares, competitors with a biodegradable medical polymers market share, detailed biodegradable medical polymers market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable medical polymers industry. This biodegradable medical polymers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biodegradable medical polymers market size has grown rapidly in recent years. It will grow from $2.78 billion in 2025 to $3.24 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to rising use of absorbable sutures, early adoption of biodegradable implants, expansion of orthopedic and cardiovascular procedures, advancements in polymer chemistry, increasing acceptance of resorbable materials.

The biodegradable medical polymers market size is expected to see rapid growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive procedures, rising focus on sustainable medical materials, expansion of drug-device combination products, growing investments in regenerative medicine, advancements in precision polymer engineering. Major trends in the forecast period include increasing use of bioabsorbable implant materials, rising demand for controlled degradation polymers, growing adoption of polymers in drug delivery systems, expansion of advanced biopolymer processing techniques, enhanced focus on biocompatibility and safety.

The rising demand for minimally invasive procedures is anticipated to fuel the expansion of the biodegradable medical polymers market in the future. Minimally invasive procedures involve medical techniques that employ small incisions or non-invasive approaches for surgeries or interventions, leading to less tissue damage, quicker recovery periods, and reduced postoperative discomfort relative to conventional surgical approaches. These procedures are on the rise thanks to progress in medical technology, which boosts the global uptake of precise surgical methods. Biodegradable medical polymers aid minimally invasive surgeries by facilitating temporary implants, sutures, and drug delivery devices that dissolve naturally in the body, eliminating the need for follow-up removal surgeries, lowering tissue injury, and accelerating patient healing with reduced risks. For example, in February 2023, the American Society of Plastic Surgeons-a US-based professional group-reported that cosmetic minimally invasive procedures grew from 23.7 million in 2022 to 25.4 million in 2023. Thus, the growing demand for minimally invasive procedures is propelling the biodegradable medical polymers market forward.

Major companies in the biodegradable medical polymers market are prioritizing cutting-edge technologies like biopolymer technology to boost the performance, biocompatibility, and sustainability of medical devices and drug delivery systems. Biopolymer technology involves the science and use of polymers from natural origins, crafted to biodegrade and support environmental health, and it produces sustainable materials for medical, packaging, and industrial uses while cutting dependence on synthetic plastics. For example, in November 2023, Sulzer Ltd., a Swiss public company based in Switzerland, unveiled CAPSUL, an innovative end-to-end licensed technology for continuously manufacturing polycaprolactone (PCL), a biodegradable polyester, which allows for high-quality PCL grades at cost-effective prices. This introduction seeks to advance sustainable and biodegradable materials, enhance production efficiency, and deliver premium eco-friendly polymers for medical and industrial purposes.

In July 2023, Evonik Industries AG, a Germany-based chemicals firm, purchased Novachem Corporation for an undisclosed sum. This acquisition allows Evonik to bolster its portfolio of sustainable cosmetic active ingredients by incorporating Novachem's innovative, biotech-derived, and eco-certified actives, while bolstering its System Solutions in the personal care sector across the Americas and advancing its shift toward sustainable specialties. Novachem Corporation, a Canada-based petrochemical firm, produces biodegradable medical polymers.

Major companies operating in the biodegradable medical polymers market are Evonik Industries AG, Corbion N.V., dsm-firmenich AG, Mitsui Chemicals Inc., Poly Medicure Limited, KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

North America was the largest region in the biodegradable medical polymers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodegradable medical polymers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodegradable medical polymers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodegradable medical polymers market consists of sales of sutures, drug delivery systems, wound dressings, orthopedic devices, dental implants, tissue engineering scaffolds, and surgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodegradable Medical Polymers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biodegradable medical polymers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodegradable medical polymers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biodegradable medical polymers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Polylactic Acid; Polyglycolic Acid; Polycaprolactone; Polyhydroxyalkanoates; Other Products
  • 2) By Material Type: Ceramic Matrix Composites (CMC); Oxide Ceramics; Non-Oxide Ceramics; Advanced Porous Ceramics
  • 3) By Product Form: Powder; Tiles; Coatings; Fibers; Bulk
  • 4) By Application: Drug Delivery; Implants; Sutures; Other Applications
  • Subsegments:
  • 1) By Polylactic Acid: Lactic Acid Derived Polymers; Copolymers Of Lactic Acid; Stereocomplex Polylactic Acid
  • 2) By Polyglycolic Acid: Homopolymers Of Glycolic Acid; Copolymers With Other Monomers
  • 3) By Polycaprolactone: Linear Polycaprolactone; Branched Polycaprolactone; Crosslinked Polycaprolactone
  • 4) By Polyhydroxyalkanoate: Polyhydroxybutyrate; Polyhydroxyvalerate; Polyhydroxybutyrate Hydroxyvalerate
  • 5) By Other Products: Starch Based Polymers; Cellulose Based Polymers; Protein Based Polymers
  • Companies Mentioned: Evonik Industries AG; Corbion N.V.; dsm-firmenich AG; Mitsui Chemicals Inc.; Poly Medicure Limited; KLS Martin SE & Co. KG; BASF SE; NatureWorks LLC; Arkema SA; Eastman Chemical Company; Foster LLC; Becton Dickinson and Company; Toray Industries Inc.; Celanese Corporation; Teysa Technologies Ltd; Kaneka Corporation; Arthrex Inc.; Ashland Inc.; Meril Life Sciences India Private Limited; Reva Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biodegradable Medical Polymers Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biodegradable Medical Polymers Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biodegradable Medical Polymers Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biodegradable Medical Polymers Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Sustainability, Climate Tech & Circular Economy
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Bioabsorbable Implant Materials
    • 4.2.2 Rising Demand For Controlled Degradation Polymers
    • 4.2.3 Growing Adoption Of Polymers In Drug Delivery Systems
    • 4.2.4 Expansion Of Advanced Biopolymer Processing Techniques
    • 4.2.5 Enhanced Focus On Biocompatibility And Safety

5. Biodegradable Medical Polymers Market Analysis Of End Use Industries

  • 5.1 Medical Device Manufacturers
  • 5.2 Pharmaceutical Companies
  • 5.3 Biotechnology Companies
  • 5.4 Research And Development Laboratories
  • 5.5 Contract Manufacturing Organizations

6. Biodegradable Medical Polymers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biodegradable Medical Polymers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biodegradable Medical Polymers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biodegradable Medical Polymers Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biodegradable Medical Polymers Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biodegradable Medical Polymers Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biodegradable Medical Polymers Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biodegradable Medical Polymers Market Segmentation

  • 9.1. Global Biodegradable Medical Polymers Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Polyhydroxyalkanoates, Other Products
  • 9.2. Global Biodegradable Medical Polymers Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ceramic Matrix Composites (CMC), Oxide Ceramics, Non-Oxide Ceramics, Advanced Porous Ceramics
  • 9.3. Global Biodegradable Medical Polymers Market, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Powder, Tiles, Coatings, Fibers, Bulk
  • 9.4. Global Biodegradable Medical Polymers Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Delivery, Implants, Sutures, Other Applications
  • 9.5. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lactic Acid Derived Polymers, Copolymers Of Lactic Acid, Stereocomplex Polylactic Acid
  • 9.6. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyglycolic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Homopolymers Of Glycolic Acid, Copolymers With Other Monomers
  • 9.7. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polycaprolactone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Linear Polycaprolactone, Branched Polycaprolactone, Crosslinked Polycaprolactone
  • 9.8. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Polyhydroxyalkanoate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polyhydroxybutyrate, Polyhydroxyvalerate, Polyhydroxybutyrate Hydroxyvalerate
  • 9.9. Global Biodegradable Medical Polymers Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Starch Based Polymers, Cellulose Based Polymers, Protein Based Polymers

10. Biodegradable Medical Polymers Market Regional And Country Analysis

  • 10.1. Global Biodegradable Medical Polymers Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biodegradable Medical Polymers Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biodegradable Medical Polymers Market

  • 11.1. Asia-Pacific Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biodegradable Medical Polymers Market

  • 12.1. China Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biodegradable Medical Polymers Market

  • 13.1. India Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biodegradable Medical Polymers Market

  • 14.1. Japan Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biodegradable Medical Polymers Market

  • 15.1. Australia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biodegradable Medical Polymers Market

  • 16.1. Indonesia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biodegradable Medical Polymers Market

  • 17.1. South Korea Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biodegradable Medical Polymers Market

  • 18.1. Taiwan Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biodegradable Medical Polymers Market

  • 19.1. South East Asia Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biodegradable Medical Polymers Market

  • 20.1. Western Europe Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biodegradable Medical Polymers Market

  • 21.1. UK Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biodegradable Medical Polymers Market

  • 22.1. Germany Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biodegradable Medical Polymers Market

  • 23.1. France Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biodegradable Medical Polymers Market

  • 24.1. Italy Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biodegradable Medical Polymers Market

  • 25.1. Spain Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biodegradable Medical Polymers Market

  • 26.1. Eastern Europe Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biodegradable Medical Polymers Market

  • 27.1. Russia Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biodegradable Medical Polymers Market

  • 28.1. North America Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biodegradable Medical Polymers Market

  • 29.1. USA Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biodegradable Medical Polymers Market

  • 30.1. Canada Biodegradable Medical Polymers Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biodegradable Medical Polymers Market

  • 31.1. South America Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biodegradable Medical Polymers Market

  • 32.1. Brazil Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biodegradable Medical Polymers Market

  • 33.1. Middle East Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biodegradable Medical Polymers Market

  • 34.1. Africa Biodegradable Medical Polymers Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biodegradable Medical Polymers Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Product Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biodegradable Medical Polymers Market Regulatory and Investment Landscape

36. Biodegradable Medical Polymers Market Competitive Landscape And Company Profiles

  • 36.1. Biodegradable Medical Polymers Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biodegradable Medical Polymers Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biodegradable Medical Polymers Market Company Profiles
    • 36.3.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Corbion N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. dsm-firmenich AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Mitsui Chemicals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Poly Medicure Limited Overview, Products and Services, Strategy and Financial Analysis

37. Biodegradable Medical Polymers Market Other Major And Innovative Companies

  • KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

38. Global Biodegradable Medical Polymers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biodegradable Medical Polymers Market

40. Biodegradable Medical Polymers Market High Potential Countries, Segments and Strategies

  • 40.1 Biodegradable Medical Polymers Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biodegradable Medical Polymers Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biodegradable Medical Polymers Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer